top of page
Profile
Join date: Mar 6, 2021
Posts
Jul 13, 2021 ∙ 2 min
CRISPR/Cas9 Gene Editing
X-linked RP caused by RPGR mutations, an attractive target for gene therapy because of its clinical severity and large number of patients.
9
0
Mar 7, 2021 ∙ 2 min
Genome Editing in Retinal Diseases using CRISPR Technology
By: Glenn Yiu, MD, PhD - Department of Ophthalmology & Vision Science, University of California, Davis, Sacramento, California
Ophthalmology
11
0
Jun 10, 2020 ∙ 1 min
New gene therapy technique
Shows promise in stem cell model of retinitis pigmentosa Although the 2017 FDA approval of Spark Therapeutics’ gene therapy Luxturna was...
5
0
Academic Paper
Writer
More actions
bottom of page